Core Insights - The article highlights that Haiponokai has been recognized as the "Leader in Dutch A2 Protein Source Infant Formula" by iiMedia Research, a leading third-party data mining and analysis agency in the new economy sector [1][5]. Industry Trends - The Chinese infant formula market is undergoing significant transformation driven by consumption upgrades and scientific feeding concepts, with 75.1% of consumers believing that scientifically formulated milk powder can effectively promote comprehensive growth in infants [3][5]. - A shift from basic nutritional competition to comprehensive value competition is noted, with a focus on A2 protein sources, breast milk simulation technology, and self-care components [3][5]. Company Positioning - Haiponokai, established in 1897, has positioned itself as a benchmark for A2 protein sources, emphasizing breast milk research as its core mission and achieving industrialized production of infant formula as early as 1938 [7][11]. - The company has integrated top-tier resources from institutions like Wageningen University and the Commonwealth Scientific and Industrial Research Organisation to form an innovative network covering nutrition science and biomedicine [7]. Product Innovation - The company utilizes its own pastures in the Dutch golden milk source belt, where only one-third of Holstein cows carry the pure A2 gene, ensuring that the milk produced contains 100% A2β-casein, which is easier for infants to digest [8][9]. - Haiponokai's "Pro59 Golden Ratio Technology" simulates over 59 nutritional components of breast milk, achieving a digestion absorption rate of 97% and significantly reducing the risk of respiratory infections by 60% [9][10]. Market Strategy - The company’s three major upgrades align with the "three movements" strategy of the maternal and infant industry, enhancing brand visibility through social media, facilitating consumer conversion through comprehensive self-care nutrition, and promoting direct engagement through promotional activities [10][11]. - As industry concentration accelerates, Haiponokai aims to redefine the value standards of high-end infant formula, marking a pivotal moment in the transition towards comprehensive nutrition and precise feeding in the Chinese market [11].
海普诺凯获艾媒咨询“荷兰A2蛋白奶源婴配奶粉领导者”市场地位确认
Zhong Guo Chan Ye Jing Ji Xin Xi Wang·2025-06-20 10:26